Dilution profile // every instrument, one screen, from SEC filings

Universe Pharmaceuticals INC (UPC)

CIK 1809616 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed sub-ratings (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGH$221M registered
= total registered offering amount from the fee exhibits of live registrations (bands: $1M / $20M)
one or more live registrations had no structured fee data, so the true total is AT LEAST this
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
LOW-97% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
HIGH~0.1 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2021-09-302025-09-30

Latest: 563,338 shares as of Sep 30, 2025 (20-F).

⊙
EVIDENCE — filed/published fact
SourceSEC XBRL, cover-page share count
Fielddei:EntityCommonStockSharesOutstanding
As of2025-09-30
HowThe newest cover-page count as filed. It is used as the current count only while it is no more than about 15 months older than the company’s newest periodic filing; the float checker applies a 200-day rule and sets it beside the balance-sheet count.
Open the source document →
Share count fell from 23.6M to 563,338 between Sep 30, 2024 and Sep 30, 2025, a pattern consistent with a reverse split (roughly 1-for-42); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

~0 months of cash left

critical · burning $1.26B / quarter

Full breakdown: cash runway tool

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

The latest 10-Q/10-K instance document could not be checked just now, so nothing is shown rather than guessed. Try again shortly.

Registrations and offerings

Registered offering capacity on live registrations: $220.6Mfrom the structured fee exhibits; registered is not remaining, takedowns are not subtracted

F-3Sep 29, 2026$220.6M registeredfiling →
F-1Apr 24, 2024no structured fee exhibit in this filing (predates fee-data XBRL or fee deferred)filing →

Last 12 months: 0 executed · 1 registered.

EFFECTIVEOct 9, 2026SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDSep 29, 2026F-3 registration — capacity to sell shares, not a sale yetF-3 →
EXECUTEDDec 9, 2024Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EXECUTEDJun 25, 2024Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
EFFECTIVEJun 7, 2024SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMay 14, 2024F-1/A registration — capacity to sell shares, not a sale yetF-1/A →
REGISTEREDApr 24, 2024F-1 registration — capacity to sell shares, not a sale yetF-1 →
EFFECTIVENov 15, 2022SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDOct 27, 2022F-3 registration — capacity to sell shares, not a sale yetF-3 →
EXECUTEDMar 24, 2021Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
EFFECTIVEMar 22, 2021SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMar 10, 2021F-1/A registration — capacity to sell shares, not a sale yetF-1/A →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full UPC workspace

Free to use. No account, no card.